By Claire Jeong, Chief Conference Officer, Vice President of Investor Research, Asia BD, LSN
Next week’s RESI Boston will showcase 50+ Innovator’s Pitch Challenge (IPC) finalists across therapeutics, medical devices, diagnostics, digital health, and more. These companies will pitch in a live session with a panel of investor and industry expert judges and engage in Q&A. We are thankful for all the judges who will be participating and providing valuable feedback and questions to the IPC finalist companies.
Whether you are an actively fundraising early-stage company, or an active investor/strategic partner looking for targeted deal-flow, it is still not too late to register, engage in partnering meetings with attendees of interest, and join our robust program of investor panels, workshops, and pitch sessions. Below is a splash of participating judges. See you all next week!
Featured IPC Judges
 Christopher Aleong Managing Director, North America BioEngine Capital |
 Paula Andrea Lengerke Diaz Advisor Desert Angels |
 Sujuan Ba President and COO NFCR Oncology Impact Partners |
 Joshua Barney Member Barrington Angels |
 Jay Batchu Analyst Xontogeny |
 Irene Blat Sr. Dir. Search & Evaluation, Oncology Servier |
 Katie Bodner Spielberg Associate 5AM Ventures |
 Bruce Cohen Venture Partner Xeraya Capital |
 Ronald Dorenbos Executive Director, Business Development, Logica Charles River Laboratories |
 Aleks Engel Partner, Novo Holdings and Director, REPAIR Impact Fund Novo Holdings A/S |
 Poorya Hosseini Partner Camford Capital |
 Tomoko Ishikura Partner Kicker Ventures |
 Hanuman Jampani Founder & President Samrus International |
 Rick Jones Partner BioAdvance |
 Deb Kemper Managing Director Golden Seeds |
 Kristin King Member Boston Harbor Angels |
 James Lee Investment Director Photon Fund |
 Seo Lee Director SV Investment |
 Nancy Levy Founder and Managing Partner BioHealth Management, LLC |
 Elliot Levy Senior Associate – Healthtech DreamIt Health |
 Bo Liang Founding Partner Alpha Bioventure |
 Yuwen Liu Founding Partner Bohe Angel Fund |
 Alyssa Reisner Director & Principal CVS Health Ventures |
 Ronak Savla Director, Strategic Ventures Catalent Strategic Ventures |
 Siyu Shi Associate F-Prime Capital |
 Christopher Tan Director, Search & Evaluation, Neuroscience and Infectious Diseases & Vaccines Merck & Co., Inc. |
 Jingjing Wang Senior Associate Lightstone Ventures |
 Sally Wang Venture Partner Viva BioInnovator |
 Tad Weems Managing Director Agilent Technologies |
 Matt Weinberg Partner Max Ventures |
 Ryan Witt Member Tech Coast Angels |
 Jacqueline Young Investor 500 Global |
 Z Haroon Chairman & General Partner Julz Co |
Next Phase Newsletter 
Leave a Reply